| C5a-inhibitory peptide combined with gabexate mesilate prevents the instant blood-mediated inflammatory reaction in a rat model of islet transplantation. | |
| | |
MedLine Citation:
|
PMID: 20692418 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
BACKGROUND: The instant blood-mediated inflammatory reaction (IBMIR), in which the activation of both the coagulation and the complement cascades plays a key role, is one of the main obstacles to successful islet transplantation. At present, however, no useful protocol is clinically available. Therefore the aim of this study was to examine whether complementary peptides against an active region of C5a were safe to suppress IBMIR, owing to their extremely low molecular mass, when combined with a clinically available anticoagulant. METHODS: Complement receptors on pancreatic tissues and isolated islets were analyzed by immunohistochemical staining and flow cytometry. Two-and-a-half islet equivalents per gram of syngeneic rat islet grafts were transplanted intraportally into 4 groups of 10-13 animals each after streptozotocin induction of diabetes: control, gabexate (Gab), C5a-inhibitory peptide (C5aINH), and C5aINH plus Gab. Recipients injected with equivalent amounts of saline solution served as control subjects. Plasma samples were collected at 0, 0.5, 1, 3, 6, and 24 h after transplantation for analysis. We also evaluated the curative rate, intravenous glucose tolerance test, and insulin amounts in the liver of the recipients. RESULTS: C3a receptor (C3aR) was scarcely expressed on the isolated islets with relatively strong expression of C5a receptor (C5aR): C3aR: 0.44 +/- 0.38%; C5aR: 7.91 +/- 2.83%). However, C5aR was not expressed on pancreatic tissues before the isolation procedures. Thrombin-antithrombin complex was significantly suppressed in the 3 treated groups (P = .0015). The curative rate was also significantly improved (0% vs 33% vs 67% vs 100%, respectively; P = .03). Glucose tolerance was significantly improved among the 3 treated groups (P < .0005). Insulin amounts in the liver were considerably higher among treated versus control hosts. Notably, the treatment did not affect the increased body weight of the recipient. CONCLUSIONS: This study suggested that C5a-inhibitory peptide combined with gabexate mesilate may be a useful approach to control the IBMIR induced in clinical islet transplantation and one that is free of side effects. |
| | |
Authors:
|
K Tokodai; M Goto; A Inagaki; W Nakanishi; N Okada; H Okada; S Satomi |
Related Documents
:
|
20097708 - {beta}-cell secretory capacity and demand in recipients of islet, pancreas, and kidney ... 17489868 - Acute gastric dilatation after porcine islet transplantation in a cynomolgus monkey - c... 10455898 - Anoikis, extracellular matrix, and apoptosis factors in isolated cell transplantation. 16298618 - Successful islet transplantation from a single pancreas harvested from a young, low-bmi... 18604068 - Synchronous rcc with nhl: a case report. 15599318 - Different evolutions in heart rate variability after heart transplantation: 10-year fol... |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't |
Journal Detail:
|
Title: Transplantation proceedings Volume: 42 ISSN: 1873-2623 ISO Abbreviation: Transplant. Proc. Publication Date: 2010 Jul-Aug |
Date Detail:
|
Created Date: 2010-08-09 Completed Date: 2011-01-14 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 0243532 Medline TA: Transplant Proc Country: United States |
Other Details:
|
Languages: eng Pagination: 2102-3 Citation Subset: IM |
Copyright Information:
|
Copyright 2010 Elsevier Inc. All rights reserved. |
Affiliation:
|
Division of Advanced Surgical Science and Technology, Tohoku University, Sendai, Japan. tsu7ka5so8mi@yahoo.co.jp |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Animals Anticoagulants / pharmacology Blood Glucose / metabolism* Complement C5a / pharmacology* Gabexate / pharmacology* Immunologic Factors / pharmacology Inflammation / prevention & control* Islets of Langerhans Transplantation / physiology* Postoperative Complications / prevention & control Rats Receptor, Anaphylatoxin C5a / genetics Transplantation, Isogeneic |
| Chemical | |
Reg. No./Substance:
|
0/Anticoagulants; 0/Blood Glucose; 0/Immunologic Factors; 0/Receptor, Anaphylatoxin C5a; 39492-01-8/Gabexate; 80295-54-1/Complement C5a |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Vascularization of artificial beds for pancreatic islet transplantation in a rat model.
Next Document: Magnetic resonance imaging of transplanted mouse islets labeled with chitosan-coated superparamagnet...